A Reversal for Microbot Medical Incorporated (NASDAQ:MBOT) Is Near. The Stock Has Decrease in Shorts

February 15, 2018 - By Kurt Siggers

 A Reversal for Microbot Medical Incorporated (NASDAQ:MBOT) Is Near. The Stock Has Decrease in Shorts

The stock of Microbot Medical Incorporated (NASDAQ:MBOT) registered a decrease of 2.76% in short interest. MBOT’s total short interest was 2.53M shares in February as published by FINRA. Its down 2.76% from 2.60 million shares, reported previously. With 891,500 shares average volume, it will take short sellers 3 days to cover their MBOT’s short positions. The short interest to Microbot Medical Incorporated’s float is 58.55%.

The stock decreased 0.18% or $0.002 during the last trading session, reaching $0.838. About 183,211 shares traded. Microbot Medical Inc. (NASDAQ:MBOT) has declined 86.60% since February 15, 2017 and is downtrending. It has underperformed by 103.30% the S&P500.

Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops next generation micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company has market cap of $39.01 million. The companyÂ’s product candidates include Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and TipCAT, a semi-disposable, flexible, and self-propelled endoscope for use in colonoscopy procedures, as well as ViRob, a revolutionary autonomous crawling micro-robot technology, which can be controlled remotely or within the body. It currently has negative earnings.

More recent Microbot Medical Inc. (NASDAQ:MBOT) news were published by: Globenewswire.com which released: “Microbot Medical’s CEO to Speak as an Industry Expert at the YJP CEO …” on February 13, 2018. Also Globenewswire.com published the news titled: “Microbot Medical Enters into Agreement to Acquire Novel Technology to Enhance …” on January 08, 2018. Globenewswire.com‘s news article titled: “Microbot Medical Inc. to Initiate Townhall Meetings” with publication date: January 31, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.